Nabriva Therapeutics plc·4

Oct 1, 4:31 PM ET

Schranz Jennifer 4

4 · Nabriva Therapeutics plc · Filed Oct 1, 2020

Insider Transaction Report

Form 4
Period: 2020-09-30
Schranz Jennifer
Chief Medical Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2020-09-30$0.53/sh301$160167,842 total

Documents

1 file
  • 4
    a4.xmlPrimary

    4